ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 1454

$1.45M Total Retail Price of All Prescriptions

Rank: 27 out of 1454

719 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 719 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 719 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 20,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 1,020 930 1 6
LISINOPRIL 900 714 2 4
HYDROCODONE-ACETAMINOPHEN 789 610 S3 3 7
OMEPRAZOLE 672 579 4 3
SIMVASTATIN 645 522 5 1
LEVOTHYROXINE SODIUM 640 549 6 5
GABAPENTIN 536 426 7 16
POTASSIUM CHLORIDE 532 456 8 15
WARFARIN SODIUM 518 436 9 17
METOPROLOL TARTRATE 452 349 10 10
AMLODIPINE BESYLATE 353 286 11 2
RISPERIDONE 352 321 12 86
CITALOPRAM HBR 345 295 13 21
LANTUS 326 265 14 51
NAMENDA 317 305 15 48
DONEPEZIL HCL 299 299 16 29
METFORMIN HCL 298 169 17 8
HYDRALAZINE HCL 286 242 18 67
NOVOLOG 277 242 19 99
CARVEDILOL 260 223 20 24
PRAVASTATIN SODIUM 256 195 21 12
ZOLPIDEM TARTRATE 250 174 22 19
TRAMADOL HCL 243 223 23 20
TAMSULOSIN HCL 224 201 24 34
FLUTICASONE PROPIONATE 221 182 25 30
POLYETHYLENE GLYCOL 3350 214 196 26 61
SERTRALINE HCL 213 180 27 26
DIVALPROEX SODIUM 209 171 28 106
LACTULOSE 205 193 29 152
TRAZODONE HCL 203 137 30 50
MIRTAZAPINE 194 166 31 53
ATORVASTATIN CALCIUM 184 136 32 11
NYSTATIN 184 175 32 184
CLOPIDOGREL 183 153 34 32
QUETIAPINE FUMARATE 181 148 35 91
HYDROCHLOROTHIAZIDE 181 155 35 9
METOPROLOL SUCCINATE 169 150 37 13
CYMBALTA 164 106 38 55
DOXYCYCLINE HYCLATE 163 124 39 110
ISOSORBIDE MONONITRATE ER 160 144 40 46
RANITIDINE HCL 159 134 41 43
ADVAIR DISKUS 155 130 42 47
PANTOPRAZOLE SODIUM 147 112 43 31
IPRATROPIUM-ALBUTEROL 146 117 44 151
FLUOXETINE HCL 142 109 45 72
CIPROFLOXACIN HCL 136 124 46 64
PLAVIX 134 102 47 45
ESCITALOPRAM OXALATE 130 89 48 78
SPIRIVA 130 109 48 52
LEVOFLOXACIN 129 119 50 95
PREDNISONE 128 94 51 36
DIGOXIN 128 118 51 70
ALLOPURINOL 125 98 53 28
GEMFIBROZIL 122 88 54 128
ROPINIROLE HCL 120 102 55 96
CARBIDOPA-LEVODOPA 118 118 56 130
PROMETHAZINE HCL 116 92 R 57 82
ATENOLOL 113 86 58 18
PHENYTOIN SODIUM EXTENDED 112 93 59 138
OXYCODONE-ACETAMINOPHEN 110 77 S2 60 60
JANTOVEN 109 109 61 100
ZETIA 109 60 61 69
CLONIDINE HCL 105 84 63 49
OLANZAPINE 101 70 64 163
OXYBUTYNIN CHLORIDE ER 100 93 65 156
NEXIUM 100 57 65 23
SINGULAIR 98 69 67 83
SUCRALFATE 97 87 68 227
JANUVIA 96 65 69 77
DIOVAN 95 68 70 40
GLIPIZIDE 93 53 71 62
SPIRONOLACTONE 92 81 72 63
CYCLOBENZAPRINE HCL 90 61 R 73 59
GLIMEPIRIDE 90 74 73 33
EXELON 88 88 75 135
KLOR-CON M20 81 57 76 54
LYRICA 81 71 76 103
NITROGLYCERIN PATCH 79 79 78 190
ALENDRONATE SODIUM 76 69 79 35
LEVETIRACETAM 75 43 80 114
OXYCODONE HCL 75 63 S2 80 80
BACLOFEN 75 40 80 146
OXYCODONE HCL-ACETAMINOPHEN 74 51 S2 83 93
AZITHROMYCIN 73 61 84 42
FORTICAL 73 64 84 336
LOVASTATIN 72 70 86 39
FENOFIBRATE 71 68 87 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 61 87 108
PAROXETINE HCL 71 55 87 73
DETROL LA 71 49 87 225
DILTIAZEM ER 70 56 91 126
CRESTOR 70 33 91 22
LIDODERM 70 66 91 158
BENZTROPINE MESYLATE 67 19 R 94 174
FAMOTIDINE 67 51 94 88
TRICOR 62 42 96 134
METFORMIN HCL ER 61 61 97 41
TIZANIDINE HCL 60 48 98 154
DICLOFENAC SODIUM 60 49 98 118
GLIPIZIDE ER 58 41 100 92
DILTIAZEM 24HR ER 57 52 101 120
FINASTERIDE 55 55 102 94
SYNTHROID 54 43 103 25
METOCLOPRAMIDE HCL 53 41 104 121
LEXAPRO 53 45 104 205
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 48 106 27
FLUCONAZOLE 52 41 106 160
FENTANYL 51 50 S2 108 104
FLUDROCORTISONE ACETATE 51 49 108 373
NYSTOP 51 51 108 245
ZIPRASIDONE HCL 51 30 108 304
TRIAMCINOLONE ACETONIDE 50 48 112 142
CEFDINIR 50 43 112 182
RAMIPRIL 50 47 112 66
ABILIFY 50 34 112 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.